- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2197-7364
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tissue dose estimation after extravasation of 177Lu-DOTATATE ; volume:8 ; number:1 ; day:31 ; month:3 ; year:2021 ; pages:1-15 ; date:12.2021
EJNMMI Physics ; 8, Heft 1 (31.3.2021), 1-15, 12.2021
- Urheber
-
Tylski, Perrine
Pina-Jomir, Géraldine
Bournaud-Salinas, Claire
Jalade, Patrice
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40658-021-00378-3
- URN
-
urn:nbn:de:101:1-2021051619314842926667
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tylski, Perrine
- Pina-Jomir, Géraldine
- Bournaud-Salinas, Claire
- Jalade, Patrice
- SpringerLink (Online service)
Ähnliche Objekte (12)
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Lymphopenia during 177Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report
Less is sometimes more – Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96 h
Einfluss der Peptid-Radio-Rezeptor-Therapie mittels 90Y- und 177Lu-DOTATATE auf die inflammatorische Atheroskleroseaktivität : Therapiemonitoring mittels serieller 68Ga-DOTATATE Positronenemissionstomographie, Computertomographie
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Lymphopenia during 177Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report
Less is sometimes more – Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96 h
Einfluss der Peptid-Radio-Rezeptor-Therapie mittels 90Y- und 177Lu-DOTATATE auf die inflammatorische Atheroskleroseaktivität : Therapiemonitoring mittels serieller 68Ga-DOTATATE Positronenemissionstomographie, Computertomographie
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Lymphopenia during 177Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report
Less is sometimes more – Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96 h
Einfluss der Peptid-Radio-Rezeptor-Therapie mittels 90Y- und 177Lu-DOTATATE auf die inflammatorische Atheroskleroseaktivität : Therapiemonitoring mittels serieller 68Ga-DOTATATE Positronenemissionstomographie, Computertomographie